Created by Wannie Chisala
over 8 years ago
|
||
Pharmacodynamics
Studying pharmacodynamics allows us to...
Pharmacokinetics
Naturally occurring sources of drugs
Synthetic source of drugs
Biologics
Drug interaction with targets
Van der waals
Hydrogen bonding
Ionic bonds
Covalent bonding
Further considerations when it comes to drug interactions with target
4 main types of target protein
Drugs acting by virtue of their physico-chemical properties
How do drugs targeting receptors work
How do drugs targeting ion channels work
Orthosteric site
Allosteric site
How do drugs that act on enzymes work
Non steroidal anti-inflammatory drugs (NSAIDs)
How do drugs working on carriers (transporters work)
Agonists
Antagonists
Types of receptor
G-protein coupled metabotropic receptors
Alpha subunit in g-protein receptor
Kinase linked receptors
Nuclear receptors
Multiple drug binding sites
Graded dose-response relationship
Quantal dose-response relationship
Why plot a dose-response curve
Efficacy
Potency
Two state hypothesis, K1
Two state hypothesis, K2
Affinity
Kd
Bmax
Use of Kd
Potency
True affinity
EC50 vs Kd
Efficacy
Full agonist
Partial agonist
Example of partial agonist
Ternary complex model
Inverse agonists
Allosteric modulators
Desensitisation of receptors
Pure antagonists
Classes of antagonists
Effect of antagonist on efficacy
Competitive antagonist
Irreversible non-competitive anagonist
Non-competitive antagonist
The dose ratio
Schild plot
Kb
PA2 values
Weak partial agonists
Competitive vs non-competitive antagonists
Therapeutic window/ index (TI)